Drug Discovery

SAS published 15 predictions for AI in health care and life sciences on April 2, 2026, covering clinical decisions, drug discovery, rural access, and pharmaceutical manufacturing. Experts said leading organizations will treat data and AI as core infrastructure in 2026.